文献速递外周动脉疾病

利用WIfI分级识别最可能从血运重建中获益的患者

Using the Society for Vascular Surgery Wound, Ischemia, and foot Infection classification to identify patients most likely to benefit from revascularization.
PubMed 文献 · J Vasc Surg · 2019-03-25

该研究回顾性分析10中心2878条慢性威胁肢体缺血患肢数据,评估WIfI分级对血运重建获益的预测价值。血运重建后1年大截肢率:1期10.8%、2期4.9%、3期5.1%、4期13.4%。聚类分析识别出4个获益程度不同的组别,伤口分级对截肢风险预测最强。

要点

  • WIfI分级可识别最可能从血运重建中获益的慢性威胁肢体缺血患者。
  • 血运重建后伤口严重程度与大截肢风险关联最强。
  • 缺血和感染分级提供相加而非协同的风险。

核心结论

  • WIfI可识别最可能从血运重建中获益的慢性威胁肢体缺血患者,并可能改善预后判断、风险分层和公平结局评估。
  • 血运重建后伤口严重程度与大截肢风险关联最强,缺血和感染分级提供相加而非协同风险。

研究设计与样本

  • 多中心嵌套队列回顾性研究,纳入10个中心2005至2015年数据,共2878条患肢,其中314条行大截肢。

主要发现

  • 血运重建亚组共1654条患肢,169条行大截肢。
  • 按原始WIfI分期,血运重建后观察到大截肢率:1期10.8%(14/130)、2期4.9%(5/103)、3期5.1%(25/487)、4期13.4%(125/934)。
  • 聚类分析识别4组,1年大截肢率分别为4.4%(46/1038)、14.8%(66/447)、28.1%(36/128)和51.2%(21/41)。
  • 多元线性回归显示伤口分级对截肢风险预测最强(F值17.25;P < .001),缺血(F值6.51;P = .001)和感染(F值5.7;P = .003)关联相似。

关键数值与推荐

  • WIfI各组分间交互项无统计学意义。

临床怎么用

  • 临床可利用WIfI分级评估慢性威胁肢体缺血患者血运重建的潜在获益,并关注伤口严重程度对截肢风险的影响。

局限性

  • 需未来比较特定WIfI表现接受与未接受血运重建的聚类分析以进一步优化WIfI。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Society of Vascular Surgery Wound Ischemia foot Infection (WIfI) classification system for chronic limb-threatening ischemia was intended to predict 1-year major lower extremity amputation (LEA) risk and to identify which patients benefit most from revascularization. We aimed to identify which WIfI presentations benefited most from revascularization to explore whether a cluster analysis could identify a more data-driven WIfI score, and to quantify which component of the WIfI score was most strongly associated with 1-year LEA after revascularization. METHODS: Composite multi-institutional nested cohort data from centers who previously validated WIfI were reviewed retrospectively. We collected each patient's WIfI component grades and whether LEA was performed. To examine the benefit of revascularization, the predicted LEA rates were subtracted from observed LEA rates. We used k-means cluster analysis to model predicted vs observed LEA rates after revascularization. Multivariable linear regression analysis was performed to quantify which WIfI score component(s) best predicted LEA. RESULTS: Data from 10 centers, accumulated between 2005 and 2015 were collated (2878 limbs at risk; 314 LEAs performed). The subset of patients who underwent revascularization comprised the study base (1654 limbs; 169 LEAs). Of 64 potential WIfI grade combinations, 15 were never reported and were excluded from the analysis. By original WIfI stages, the observed LEA rate after revascularization was: stage 1, 10.8% (14/130); stage 2, 4.9% (5/103); stage 3, 5.1% (25/487); and stage 4, 13.4% (125/934). Based on the difference between predicted and observed LEA risk for those who underwent revascularization, the WIfI scores were placed into quartiles from greatest to no benefit of revascularization. Cluster analysis identified four clusters with the following 1-year LEA rates: cluster 1, 4.4% (46/1038); cluster 2, 14.8% (66/447); cluster 3, 28.1% (36/128); and cluster 4, 51.2% (21/41). The between sum of squares/total sum of squares was 93.9%. Multiple linear regression revealed the wound grade most strongly predicted LEA (F-value, 17.25; P < .001). Ischemia (F-value, 6.51; P = .001) and infection (F-value, 5.7; P = .003) were similarly associated with LEA risk. Interaction terms between each component of the WIfI score were not statistically significant. CONCLUSIONS: WIfI can identify which patients with chronic limb-threatening ischemia are most likely to benefit from revascularization and may provide improved prognostication, risk stratification, and equitable outcome assessments. After revascularization, wound severity is most strongly associated with LEA risk. Ischemic and infectious grades confer additive, but not synergistic, risk. Future cluster analyses comparing specific WIfI presentations treated with and without revascularization will be required to further refine WIfI.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Mayor J, Chung J, Zhang Q, et al. Using the Society for Vascular Surgery Wound, Ischemia, and foot Infection classification to identify patients most likely to benefit from revascularization. J Vasc Surg. 2019. PMID: 30922742. doi:10.1016/j.jvs.2018.11.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。